Yahoo Web Search

Search results

1. People also ask

   Is Moderna stock undervalued?

   • Sales are up despite higher costs, thanks to the company’s consumer-centric, beverage portfolio and packaging innovations. Source: Source: Morningstar Direct. Data as of August 6, 2024. With a 5-star rating, Moderna stock is significantly undervalued compared with our fair value estimate.

   After Earnings and a Big Selloff, Is Moderna Stock a Buy?

   www.morningstar.com/stocks/after-earnings-big-selloff-is-moderna-stock-buy

   See all results for this question

   What happened to Moderna stock?

   • What happened Shares of Moderna(NASDAQ: MRNA)were down by 5.3% as of 1:25 p.m. ET Wednesday. The company announced a long-term collaboration with Thermo Fisher Scientificto manufacture messenger RNA (mRNA) vaccines. However, that wasn't the reason why Moderna's stock price slid.

   Why Moderna Stock Is Falling Today | Nasdaq

   www.nasdaq.com/articles/why-moderna-stock-is-falling-today

   See all results for this question

   Does Moderna have a cost-cutting plan?

   • Moderna has also announced substantial cost-cutting measures, including cuts to its research and development (R&D) spending, which has raised concerns about its future growth. Investors are also wary of the company’s timeline to achieve profitability, which has been pushed out to 2028. Is Moderna Right to Cut Costs?

   Is Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels?

   finance.yahoo.com/news/moderna-nasdaq-mrna-stock-buy-150650833.html

   See all results for this question

   How strong is Moderna?

   • Moderna’s massive covid-19 vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, and given the firm’s lack of debt, financial strength looks solid. Read more about Moderna’s financial strength.

   After Earnings and a Big Selloff, Is Moderna Stock a Buy?

   www.morningstar.com/stocks/after-earnings-big-selloff-is-moderna-stock-buy

   See all results for this question

   How much money will Moderna make by 2032?

   • Overall, this results in $21 billion in total probability-adjusted annual revenue by 2032. We expect operating margins will surpass 40% by 2030 and model long-term margins approaching 50%, even with continued strong investment in research and development. Read more about Moderna’s fair value estimate. Source: Source: Morningstar Direct.

   After Earnings and a Big Selloff, Is Moderna Stock a Buy?

   www.morningstar.com/stocks/after-earnings-big-selloff-is-moderna-stock-buy

   See all results for this question

   Will Moderna return to profitability in 2027?

   • These changes push back the potential timing of Moderna’s return to profitability to 2027, but we think the firm has plenty of cash to sustain this timeline, as new launches could help reduce cash burn starting in 2025.

   After Earnings and a Big Selloff, Is Moderna Stock a Buy?

   www.morningstar.com/stocks/after-earnings-big-selloff-is-moderna-stock-buy

   See all results for this question

2. Top stories

   • 

     Insider Monkey on MSN.com

     Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?

     3 days ago

   • 

     Insider Monkey on MSN.com

     Is Moderna Inc. (MRNA) the Best QQQ Stock to Buy According to Analysts?

     2 weeks ago

   • 

     Yahoo Finance

     Why Is Moderna Stock Trading Higher On Monday?

     5 days ago

   View all

3. www.morningstar.com › stocks › after-earnings-bigAfter Earnings and a Big Selloff, Is Moderna Stock a Buy?

   www.morningstar.com › stocks › after-earnings-big

   • Cached

   Aug 7, 2024 · With a 5-star rating, Moderna stock is significantly undervalued compared with our fair value estimate.

4. www.morningstar.com › stocks › moderna-shares-remainModerna: Shares Remain Deeply Undervalued, Despite Our Lower ...

   www.morningstar.com › stocks › moderna-shares-remain

   • Cached

   Oct 16, 2023 · Key Morningstar Metrics for Moderna. Fair Value Estimate: $227.00. Morningstar Rating: 5 stars. Morningstar Economic Moat Rating: None. Morningstar Uncertainty Rating: Very High.

5. seekingalpha.com › article › 4524549-modernaModerna: Undervalued Despite The Robust Demand Outlook

   seekingalpha.com › article › 4524549-moderna

   Jul 20, 2022 · Comparing Moderna's financial multiples with the multiples of its peers shows that the stock looks attractive and is undervalued. I evaluate that MRNA has a fair value of $328. 1Q 2022...

6. finance.yahoo.com › news › moderna-nasdaq-mrna-stockIs Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels?

   finance.yahoo.com › news › moderna-nasdaq-mrna-stock

   • Cached

   2 days ago · Is Moderna Right to Cut Costs? Another reason I’m Neutral on MRNA stock is the company’s decision to implement significant cost-cutting measures, including a $1.1 billion reduction by 2027.

7. www.morningstar.com › stocks › moderna-shares-remainModerna Shares Remain Undervalued Following Superior Data for ...

   www.morningstar.com › stocks › moderna-shares-remain

   • Cached

   Jun 9, 2022 · We see Moderna shares as undervalued, with significant potential for the firm’s mRNA technology to support further updates to COVID vaccines as well as additional respiratory virus vaccines in...

8. stockanalysis.com › stocks › mrnaModerna, Inc. (MRNA) Stock Price, Quote & News - Stock Analysis

   stockanalysis.com › stocks › mrna

   • Cached

   1 day ago · Get a real-time Moderna, Inc. (MRNA) stock price quote with breaking news, financials, statistics, charts and more.

9. seekingalpha.com › article › 4505756-moderna-stockModerna Stock: Undervalued Ahead Of Q1 Earnings - Seeking Alpha

   seekingalpha.com › article › 4505756-moderna-stock

   May 2, 2022 · Check out my fair price for MRNA and see why I think it's undervalued ahead of Q1 earnings. Moderna expects to sell more COVID-19 vaccines in 2022 than in 2021.